MedTrace Logo

SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart

NCT03574012 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2024-01-23

No results posted yet for this study

Summary

This pilot trial studies how well education and mobile health applications work in reducing the effects of cancer treatment on the heart in participants with blood cancers that are in remission. Education and mobile health applications may be effective ways to manage heart health and to reduce future heart disease risk in participants with blood cancers.

Conditions

  • Acute Leukemia in Remission
  • Hematopoietic Cell Transplantation Recipient
  • Lymphoma

Interventions

DEVICE

Monitoring Device

Use Fitbit tracker

OTHER

Informational Intervention

Receive individualized health and fitness information from clinician, supplemented with peer support through the study's social media platform

OTHER

Informational Intervention

Receive general health and fitness information from clinician

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Eric Chow · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-31
Primary Completion
2020-01-22
Completion
2020-06-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03574012 on ClinicalTrials.gov